HomeTagsHealthcare AI

healthcare AI - Page 2

Latest

AI Screened 6,680 Molecules and Helped Find a New Antibiotic, Abaucin

An AI model ranked 6,680 compounds in under two hours and helped find abaucin, which treated superbug infections in mice. It isn't a medicine yet.

Dermatologist’s Test Finds a 2015 AI Beats Two LLMs on Skin Cancer

A Guy's dermatologist's self-published test found a 2015 image model named 62% of 200 skin lesions correctly, against 42% for GPT-6 Astra and Claude.

Fudan-Led AI Builds Rare Gut-Lesion Training Images From One Photo

EndoRare, a Fudan-led AI model in Nature Communications, makes varied images of four rare gut conditions from one photo to train classifiers and novices.

St Jude Says Its Open-Source MyGPT AI Can Run on a $1,839 Mac Mini

St Jude researchers have published MyGPT, an open-source AI that answers questions from private documents without sending data outside the building.

Google Says Partner’s AI Has Read 25,000 X-Rays in TB Screening

Google says an AI tool built on its model has read 25,000+ chest X-rays in about 40 African clinics, as Indonesia tunes MedGemma for TB screening.

AI Eye Exams Closed a Youth Diabetes Screening Gap, Study Says

A Johns Hopkins trial found AI eye exams at diabetes clinics lifted youth screening to 98-99.5% and closed a White v non-White gap - but only in Baltimore.

Stanford Says Immune Digital Twins Flag a Drug Pair for Preterm Labour

Stanford-led researchers built immune digital twins of pregnancy that flagged aspirin plus lansoprazole. The evidence so far is model and animal data.

KCL AI Spots DNA-Repair Defect in Ovarian Cancer From Routine Slides

A King's College London-led model reads routine tissue slides to flag HRD in ovarian cancer, with an AUC of 0.846. It is not yet a clinical test.

Microsoft Diagnostic AI Scored 83% on Past Cases, Science Paper Says

Microsoft's MAI-DxO diagnosed 83% of complex past cases against 36% for doctors in a Science benchmark study. No product, approval or date is announced.

Sophont’s Holon-S1 Aims to Predict Tumour Gene Activity From Routine Slides

Sophont's Holon-S1 predicts spatial gene and pathway activity from routine H&E slides. It is for research use only, and results so far are the company's.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.